Kulka Marianna, Alexopoulou Lena, Flavell Richard A, Metcalfe Dean D
Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1881, USA.
J Allergy Clin Immunol. 2004 Jul;114(1):174-82. doi: 10.1016/j.jaci.2004.03.049.
Although mast cells (MCs) have been clearly implicated in innate immune responses involving bacteria, their ability to respond to viral infection is less clear.
Given that MCs increase at sites of inflammation and are located at surfaces where exposure to invading viruses may occur, we explored the ability of MCs to produce cytokines including type I IFNs after exposure to viruses and to polyinosine-polycytidylic acid (polyI:C), a synthetic mimic of viral double-stranded RNA, and characterized the receptors involved, if any.
Human peripheral blood-derived cultured MCs and 2 MC lines, Laboratory of Allergic Disease MC line and human MC line 1, were stimulated with viruses and polyI:C, and cytokine production, degranulation, and signaling pathway activation were examined. Because polyI:C is a ligand for Toll-like receptor (TLR)-3, human MCs were also analyzed for TLR expression.
Viruses and polyI:C induced IFN-alpha and IFN-beta production. PolyI:C did not induce TNF, IL-1beta, IL-5, or GM-CSF production, in contrast with other TLR ligands (LPS, peptidoglycan, CpG-A, or flagellin). IFN-alpha production involved nuclear factor-kappaB, p38, and C-Jun NH2-terminal kinase and mitogen-activated protein kinase. RT-PCR and Western blot analysis confirmed expression of TLR-3 by all MCs. Human cultured MCs also expressed TLR-1, TLR-2, TLR-4, TLR-5, TLR-6, TLR-7 and TLR-9. Antibodies to TLR-3 significantly decreased IFN-alpha production. Bone marrow-derived MCs from TLR-3 knockout mice showed an ablated response to polyI:C.
Murine and human MCs produce type I IFNs after exposure to double-stranded RNA and/or virus, the former via specific interactions with TLR-3. These data suggest that MCs contribute to innate immune responses to viral infection via the production of type I IFNs.
尽管肥大细胞(MCs)在涉及细菌的先天性免疫反应中所起作用已明确,但它们对病毒感染的反应能力尚不清楚。
鉴于肥大细胞在炎症部位数量增加且位于可能接触入侵病毒的表面,我们探讨了肥大细胞在接触病毒和聚肌苷酸-聚胞苷酸(polyI:C,一种病毒双链RNA的合成类似物)后产生包括I型干扰素在内的细胞因子的能力,并对相关受体(若存在)进行了特征分析。
用病毒和polyI:C刺激人外周血来源的培养肥大细胞以及两种肥大细胞系,即变应性疾病实验室肥大细胞系和人肥大细胞系1,检测细胞因子产生、脱颗粒和信号通路激活情况。由于polyI:C是Toll样受体(TLR)-3的配体,还分析了人肥大细胞的TLR表达情况。
病毒和polyI:C诱导干扰素-α和干扰素-β产生。与其他TLR配体(脂多糖、肽聚糖、CpG-A或鞭毛蛋白)不同,polyI:C未诱导肿瘤坏死因子、白细胞介素-1β、白细胞介素-5或粒细胞-巨噬细胞集落刺激因子产生。干扰素-α的产生涉及核因子-κB、p38和C-Jun氨基末端激酶以及丝裂原活化蛋白激酶。逆转录-聚合酶链反应(RT-PCR)和蛋白质印迹分析证实所有肥大细胞均表达TLR-3。人培养肥大细胞还表达TLR-1、TLR-2、TLR-4、TLR-5、TLR-6、TLR-7和TLR-9。TLR-3抗体显著降低干扰素-α的产生。来自TLR-3基因敲除小鼠的骨髓来源肥大细胞对polyI:C无反应。
小鼠和人肥大细胞在接触双链RNA和/或病毒后产生I型干扰素,前者通过与TLR-3的特异性相互作用产生。这些数据表明肥大细胞通过产生I型干扰素参与对病毒感染的先天性免疫反应。